Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYVBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation AuthorityPREV STORYEnzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness